Grislim 125 Tablet contains Griseofulvin 125mg, a well-established systemic antifungal agent used for the treatment of dermatophyte infections involving the skin, scalp, hair, and nails. It works by inhibiting fungal cell division and preventing the spread of infection.
This formulation is commonly prescribed for conditions such as tinea capitis, tinea corporis, tinea cruris, and onychomycosis where topical therapy alone is insufficient. Its systemic action ensures effective penetration into keratinized tissues, providing long-term fungal control.
Griseofulvin remains a preferred choice in dermatology practice for chronic and resistant fungal infections. The 125mg strength allows flexible dosing across pediatric and adult patients under medical supervision, supporting broad clinical use.
Grislim 125 Tablet strengthens any dermatology and antifungal therapy segment, offering consistent demand in clinics, hospitals, pharmacies, and export markets. Its proven efficacy and wide prescriber acceptance make it a dependable product for pharmaceutical distribution and manufacturing portfolios.